SCHEMBL3145197

SCHEMBL3145197

COC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(CNC(N)=O)cc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.40
DRD2 P14416 1/20 0.40
NAMPT P43490 3/20 0.39
MAPT P10636 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
PDPK1 O15530 2/20 0.38
AKT2 P31751 2/20 0.38
BACE1 P56817 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3145182 1.00 HIF1A (0.40) HIF1ADRD2NAMPTMAPTCA1
SCHEMBL3144532 0.93 HIF1A (0.39) HIF1ADRD2NAMPTMAPTCA1
SCHEMBL2573273 0.92 MAPT (0.51) NAMPTMAPTKMT2AMEN1SMN1; SMN2
SCHEMBL2573269 0.92 MAPT (0.51) NAMPTMAPTKMT2AMEN1SMN1; SMN2
SCHEMBL3148605 0.92 PTPN1 (0.42) HIF1ADRD2NAMPTMAPTCA1
SCHEMBL3148593 0.92 PTPN1 (0.42) HIF1ADRD2NAMPTMAPTCA1
SCHEMBL480558 0.90 HIF1A (0.44) HIF1ANAMPTMAPTCA1CA2
SCHEMBL480555 0.90 HIF1A (0.44) HIF1ANAMPTMAPTCA1CA2
SCHEMBL1116392 0.90 HIF1A (0.42) HIF1ADRD2NAMPTMAPTCA1
SCHEMBL31094000 0.90 HIF1A (0.42) HIF1ADRD2NAMPTMAPTCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224170-B9 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2017-11-22 EP disclosed
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
EP-1224170-B1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed